Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1

Status

Completed 11Terminated 4Unknown 3Recruiting 1No longer available 1Active not recruiting 1

Sponsor Class

OTHER_GOV 1OTHER 1NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Plasma cell 3Other hematologic neoplasm 1Lymphoid 1

Conditions

Leukemia, Myeloid, Acute 55Leukemia 35Precursor Cell Lymphoblastic Leukemia-Lymphoma 27Lymphoma 21Lymphoma, Large B-Cell, Diffuse 18Lymphoma, Non-Hodgkin 13Leukemia, Monocytic, Acute 10Lymphoma, Mantle-Cell 9Leukemia, Myelomonocytic, Acute 9Leukemia, Megakaryoblastic, Acute 8Leukemia, Erythroblastic, Acute 8Recurrence 7Myelodysplastic Syndromes 7Burkitt Lymphoma 7Lymphoma, Large-Cell, Immunoblastic 6Lymphoma, Follicular 5Leukemia, Myelogenous, Chronic, BCR-ABL Positive 5Congenital Abnormalities 5Leukemia, Myeloid, Chronic-Phase 4Hodgkin Disease 4Multiple Myeloma 3Leukemia, Promyelocytic, Acute 3Leukemia, Eosinophilic, Acute 3Leukemia, Basophilic, Acute 3Anemia, Refractory, with Excess of Blasts 3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Lymphoma, Large-Cell, Anaplastic 2Lymphoma, B-Cell, Marginal Zone 2Leukemia, T-Cell 2Leukemia, Myelomonocytic, Chronic 2

Interventions

Dexamethasone 64Cyclophosphamide 40Bortezomib 37Melphalan 24Lenalidomide 23Thalidomide 17pomalidomide 16fludarabine 12daratumumab 11carfilzomib 10Filgrastim 8Doxorubicin 8Busulfan 6Prednisone 5Peripheral Blood Stem Cell Transplantation 5Bendamustine Hydrochloride 5selinexor 4sargramostim 4isatuximab 4fludarabine phosphate 4Surveys and Questionnaires 4Etoposide 4Clarithromycin 4Calcium Dobesilate 4liposomal doxorubicin 3ixazomib 3Radiotherapy 3Neoadjuvant Therapy 3Mycophenolic Acid 3Methylprednisolone 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × Multiple Myeloma × Cytarabine × Clear all
NCT05536154 2024-03-19

Etoposide+Cytarabine+PEG-rhG-CSF as First Line Mobilization Regimen of Hematopoietic Stem Cells in Patients With Hematological Malignancies

The Affiliated People's Hospital of Ningbo University

Phase NA Unknown
68 enrolled
LymphoidOther hematologic neoplasmPlasma cell

Lymphoma, Multiple Myeloma, Hematologic Neoplasms

NCT03570983 2022-06-22

BEAM

Swedish Medical Center

Phase 2 Unknown
100 enrolled
Plasma cell

Multiple Myeloma

NCT00004903 2014-01-06

Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma

National Cancer Institute (NCI)

Phase 2 Unknown
Plasma cell

Multiple Myeloma, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡